CRISPR Therapeutics AG
(CRSP)
undefined
undefined%
At close: undefined
43.85
0.23%
After-hours Dec 13, 2024, 07:08 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
| Cash & Equivalents | 389.48M | 211.88M | 923.03M | 1.17B | 943.77M | 456.65M | 239.76M | 315.52M | 155.96M | 945.00K |
| Short-Term Investments | 1.30B | 1.60B | 1.46B | 521.71M | - | - | - | - | - | - |
| Long-Term Investments | 1.97M | 53.13M | 16.91M | 16.85M | 5.04M | 3.16M | 3.15M | 3.15M | 700.00K | - |
| Other Long-Term Assets | 13.57M | 16.27M | 22.20M | 18.14M | 6.14M | 3.83M | 3.76M | 3.35M | 801.00K | 50.00K |
| Receivables | 200.00M | - | 305.00K | 144.00K | 99.00K | 88.00K | 2.63M | 3.16M | 339.00K | - |
| Inventory | - | -11.20M | - | - | 1.00 | 1.00 | 1.00 | - | 1.00 | - |
| Other Current Assets | 14.39M | 37.71M | 29.68M | 15.44M | 6.98M | 15.92M | 12.00M | 3.02M | 540.00K | 23.00K |
| Total Current Assets | 1.91B | 1.85B | 2.42B | 1.72B | 987.55M | 466.39M | 248.38M | 320.19M | 156.84M | 968.00K |
| Property-Plant & Equipment | 305.94M | 320.56M | 312.04M | 93.03M | 72.83M | 18.50M | 18.86M | 21.03M | 1.33M | - |
| Goodwill & Intangibles | 16.00K | 71.00K | 125.00K | 180.00K | 235.00K | 289.00K | 344.00K | 399.00K | 454.00K | 509.00K |
| Total Long-Term Assets | 321.49M | 390.03M | 334.36M | 111.35M | 79.20M | 22.62M | 22.96M | 24.77M | 2.58M | 559.00K |
| Total Assets | 2.23B | 2.24B | 2.75B | 1.83B | 1.07B | 489.02M | 271.35M | 344.96M | 159.42M | 1.53M |
| Account Payables | 38.15M | 27.43M | 14.82M | 9.09M | 5.94M | 5.07M | 1.64M | 4.57M | 1.58M | 211.00K |
| Deferred Revenue | 4.11M | 12.32M | 1.01M | 2.34M | 960.00K | 57.78M | 56.93M | 77.65M | - | - |
| Short-Term Debt | 31.25M | 31.68M | 24.32M | 22.72M | 16.98M | - | - | - | - | - |
| Other Current Liabilities | 34.85M | 61.86M | 79.02M | 49.63M | 32.64M | 22.27M | 12.53M | 17.41M | 8.49M | 1.92M |
| Total Current Liabilities | 108.79M | 121.11M | 119.88M | 94.26M | 57.11M | 27.75M | 14.51M | 22.00M | 10.15M | 2.15M |
| Long-Term Debt | 223.01M | 228.18M | 212.87M | 50.07M | 44.05M | - | - | - | -26.18M | - |
| Other Long-Term Liabilities | 958.00K | 5.97M | 7.34M | 7.63M | 14.39M | 11.29M | 12.07M | 12.47M | -64.08M | 6.36M |
| Total Long-Term Liabilities | 237.98M | 246.47M | 232.53M | 69.47M | 70.22M | 69.08M | 69.00M | 90.12M | 178.39M | 6.36M |
| Total Liabilities | 346.77M | 367.58M | 352.42M | 163.73M | 127.33M | 96.82M | 83.51M | 112.12M | 188.55M | 8.50M |
| Total Debt | 238.63M | 244.02M | 225.03M | 61.43M | 52.54M | - | - | - | 38.34M | - |
| Common Stock | 2.50M | 2.44M | 2.39M | 2.28M | 1.85M | 1.58M | 1.24M | 1.22M | 181.00K | 120.00K |
| Retained Earnings | -999.70M | -846.09M | -195.91M | -573.58M | -224.71M | -291.57M | -125.44M | -57.08M | -33.91M | -8.40M |
| Comprehensive Income | 1.91M | -15.65M | -5.07M | -83.00K | 7.00K | -8.00K | 14.00K | -26.00K | -8.00K | -2.00K |
| Shareholders Equity | 1.88B | 1.88B | 2.40B | 1.66B | 939.42M | 392.19M | 187.83M | 232.85M | -29.10M | -7.12M |
| Total Investments | 1.31B | 1.66B | 1.46B | 521.71M | 5.04M | 3.16M | 3.15M | 3.15M | 700.00K | - |